Send to

Choose Destination
Neurogastroenterol Motil. 2007 Jan;19(1 Suppl):89-119.

Serotonergic and non-serotonergic targets in the pharmacotherapy of visceral hypersensitivity.

Author information

Neurogastroenterology Unit INRA, Toulouse, France.


Visceral hypersensitivity is considered a key mechanism in the pathogenesis of functional gastrointestinal (GI) disorders. Targeting visceral hypersensitivity seems an attractive approach to the development of drugs for functional GI disorders. This review summarizes current knowledge on targets for the treatment of visceral hypersensitivity, and the status of current and future drug and probiotic treatment development, and the role of pharmacogenomic factors.

[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center